Using the HEL AML cell line, which carries a monoallelic TET2 deletion, Stölzel and colleagues generated a CRISPR knockout isogenic cell line pair with a biallelic TET2 mutation. This evidence concerns the gene TET2 and acute myeloid leukemia.